Journal: British Journal of Cancer

Article Title: Key Roles for MYC , KIT and RET signaling in secondary angiosarcomas

doi: 10.1038/bjc.2014.359

Figure Lengend Snippet: Selected deregulated genes with their respective fold changes

Article Snippet: The antibodies used were KIT (A4502, Dilution 1 : 400, Dako), RET (MA1-26379, Dilution 1 : 25, Thermo Scientific, Waltham, MA, USA), CDKN2C (NB120-3216, Dilution 1 : 25, Novus Biologicals, Cambridge, UK) and KDR (Clone 55B11, Dilution 1 : 100, Cell Signaling, Danvers, MA, USA).

Techniques:

Journal: British Journal of Cancer

Article Title: Key Roles for MYC , KIT and RET signaling in secondary angiosarcomas

doi: 10.1038/bjc.2014.359

Figure Lengend Snippet: Scatterplots demonstrating the RT–qPCR expression ratios (Y-axis) in primary and secondary angiosarcomas (X-axis) in relation to the pooled reference genes. In secondary angiosarcoma upregulation affects ( A ) MYC and ( B ) RET, whereas downregulation is demonstrated for ( C ) CDKN2C.

Article Snippet: The antibodies used were KIT (A4502, Dilution 1 : 400, Dako), RET (MA1-26379, Dilution 1 : 25, Thermo Scientific, Waltham, MA, USA), CDKN2C (NB120-3216, Dilution 1 : 25, Novus Biologicals, Cambridge, UK) and KDR (Clone 55B11, Dilution 1 : 100, Cell Signaling, Danvers, MA, USA).

Techniques: Quantitative RT-PCR, Expressing

Journal:

Article Title: Identification of Risk and Age-at-Onset Genes on Chromosome 1p in Parkinson Disease

doi:

Figure Lengend Snippet: SNPs Analyzed [Note]

Article Snippet: 151 , rs12855 , CDKN2C , C__8847082_10 , 49726604 , 50810011 , 10.0 , .438 , .708.

Techniques:

Journal: Cancer medicine

Article Title: The expression and role of SUZ12 in lung adenocarcinoma.

doi: 10.1002/cam4.70190

Figure Lengend Snippet: FIGURE 8 The effect of SUZ12 on CKIs, p53, and Rb expression was tested by qRT-PCR and western blotting. sh-SUZ12 decreased p57 mRNA expression (A) and p18/p19/p-p53 protein expression (B) and (D), while increased p57/Rb/pRb protein expression (B) and (D), without significantly effected the p53 and Rb mRNA expression (C). *p < 0.05, **p < 0.001.

Article Snippet: The list of primary antibodies: SUZ12 (1 μg/mL, Abcam Cambridge, cat no: ab12073), CDK2 (1:1000; Proteintech, USA, cat. no. 10122- 1- AP), CDK3 (1:2000; Proteintech, USA, cat. no. 55103- 1- AP), CDK6 (1:2000; Proteintech, USA, cat. no. 14052- 1- AP), cyclin D1 (1:5000; Proteintech, USA, cat. no. 26939- 1- AP), cyclin E1 (1:1000; Proteintech, USA, cat. no. 11554- 1- AP), p18 (1:1000, BOSTER China, cat. no. M03299- 1), p19 (1:1000, BOSTER China, cat. no. MA1075), p53 (1:5000; Proteintech, USA, cat. no. 60283- 2- Ig), p- p53 (1:2000; Proteintech, USA, cat. no. 28961- 1- AP), p57 (1:1000, BOSTER China, cat. no. BM4129), Rb (1:1000, BOSTER China, cat. no. BM4500), pRb (1:1000, BOSTER China, cat. no. BM4338), Bcl- 2 (1:1000; Proteintech, USA, cat. no. 26593- 1- AP), Bax (1:2000; Proteintech, USA, cat. no. 50599- 2- lg), Ecadherin (1:5000; Proteintech, USA, cat. no. 20874- 1- AP), N- cadherin (1:3000; Proteintech, USA, cat. no. 22018- 1- AP), vimentin (1:4000; Proteintech, USA, cat. no. 10366- 1- AP), MMP1 (1:1000, BOSTER China, cat. no. A00733- 1), MMP2 (1:500, BOSTER China, cat. no. BM4075), MMP9 (1:1000, BOSTER China, cat. no. PB0709), MMP14 (1:1000, BOSTER China, cat. no. BM4119), TIMP1 (1:1000, Bioss China, cat. no. bs0415R), TIMP2 (1:1000, Bioss China, cat. no. bs- 10395R), TIMP3 (1:1000; Proteintech, USA, cat. no. 10858- 1- AP), ITGB1 (1:1000, BOSTER China, cat. no. BM4308), ITGB3 (1:1000, BOSTER China, cat. no. BA1670), ITGB5 (1:1000, BOSTER China, cat. no. A04201- 1), nm23 (1:1000, BOSTER China, cat. no. BA3787), PD- L1 (1:3000; Proteintech, USA, cat. no. 66248- 1- Ig), and βactin (1:5000; Proteintech, USA, cat. no. 66009- 1- Ig).

Techniques: Expressing, Quantitative RT-PCR, Western Blot

Journal: Arquivos Brasileiros de Cardiologia

Article Title: Congenital Heart Disease as a Warning Sign for the Diagnosis of the 22q11.2 Deletion

doi: 10.5935/abc.20140145

Figure Lengend Snippet: Demonstration of the deletion in region 22q11.2. A. FISH technique. B. MLPA technique.

Article Snippet: Commercial probes of unique sequences were used for the specific region in 22q11.2 (probes DGS/VCFS, TUPLE1 and N25 D22S75, Cytocell, Cambridge, UK) , and/or MLPA using various kits (P036-E1, P070-B2, P064-B3, MRC-Holland, Amsterdam, Netherlands - www.mlpa.com ).

Techniques:

Journal: Arquivos Brasileiros de Cardiologia

Article Title: Congenital Heart Disease as a Warning Sign for the Diagnosis of the 22q11.2 Deletion

doi: 10.5935/abc.20140145

Figure Lengend Snippet: Congenital heart diseases in 47 patients with the 22q11.2 deletion syndrome and the surgical corrections performed

Article Snippet: Commercial probes of unique sequences were used for the specific region in 22q11.2 (probes DGS/VCFS, TUPLE1 and N25 D22S75, Cytocell, Cambridge, UK) , and/or MLPA using various kits (P036-E1, P070-B2, P064-B3, MRC-Holland, Amsterdam, Netherlands - www.mlpa.com ).

Techniques:

Journal: Arquivos Brasileiros de Cardiologia

Article Title: Congenital Heart Disease as a Warning Sign for the Diagnosis of the 22q11.2 Deletion

doi: 10.5935/abc.20140145

Figure Lengend Snippet: Phenotypic characteristics of 60 patients with the 22q11.2 deletion syndrome

Article Snippet: Commercial probes of unique sequences were used for the specific region in 22q11.2 (probes DGS/VCFS, TUPLE1 and N25 D22S75, Cytocell, Cambridge, UK) , and/or MLPA using various kits (P036-E1, P070-B2, P064-B3, MRC-Holland, Amsterdam, Netherlands - www.mlpa.com ).

Techniques:

Journal: Arquivos Brasileiros de Cardiologia

Article Title: Congenital Heart Disease as a Warning Sign for the Diagnosis of the 22q11.2 Deletion

doi: 10.5935/abc.20140145

Figure Lengend Snippet: Main phenotypic characteristics of patients with the 22q11.2 deletion syndrome. A) Narrow palpebral fissure. B) Elongated face and/or nose. C) Thin lips.

Article Snippet: Commercial probes of unique sequences were used for the specific region in 22q11.2 (probes DGS/VCFS, TUPLE1 and N25 D22S75, Cytocell, Cambridge, UK) , and/or MLPA using various kits (P036-E1, P070-B2, P064-B3, MRC-Holland, Amsterdam, Netherlands - www.mlpa.com ).

Techniques:

Journal: Arquivos Brasileiros de Cardiologia

Article Title: Congenital Heart Disease as a Warning Sign for the Diagnosis of the 22q11.2 Deletion

doi: 10.5935/abc.20140145

Figure Lengend Snippet: Pictures showing evolving features of patients with the 22q11.2 deletion syndrome at different ages. A) Newborn with thin lips and dysplasic ears. These phenotypic features become more characteristic at school age. B) Newborn with facial dysmorphism (elongated face and nose, narrow palpebral fissure, thin lips). C) Infant with elongated face and nose more evident during development

Article Snippet: Commercial probes of unique sequences were used for the specific region in 22q11.2 (probes DGS/VCFS, TUPLE1 and N25 D22S75, Cytocell, Cambridge, UK) , and/or MLPA using various kits (P036-E1, P070-B2, P064-B3, MRC-Holland, Amsterdam, Netherlands - www.mlpa.com ).

Techniques:

Journal: Arquivos Brasileiros de Cardiologia

Article Title: Congenital Heart Disease as a Warning Sign for the Diagnosis of the 22q11.2 Deletion

doi: 10.5935/abc.20140145

Figure Lengend Snippet: Distribution of values of total lymphocytes, CD4 + , CD8 + and CD19 + in patients with the 22q11.2 deletion syndrome. A) Number of total lymphocytes. B) CD4 + count. C) CD8 + count. D) CD19 + count. Each dot ( • ) corresponds to an individual patient. Max: Maximum; Min: Mimum

Article Snippet: Commercial probes of unique sequences were used for the specific region in 22q11.2 (probes DGS/VCFS, TUPLE1 and N25 D22S75, Cytocell, Cambridge, UK) , and/or MLPA using various kits (P036-E1, P070-B2, P064-B3, MRC-Holland, Amsterdam, Netherlands - www.mlpa.com ).

Techniques: